OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel approaches for vaccine development
Makda S. Gebre, Luis A. Brito, Lisa H. Tostanoski, et al.
Cell (2021) Vol. 184, Iss. 6, pp. 1589-1603
Open Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

Lipid nanoparticles for mRNA delivery
Xucheng Hou, Tal Zaks, Róbert Langer, et al.
Nature Reviews Materials (2021) Vol. 6, Iss. 12, pp. 1078-1094
Open Access | Times Cited: 2249

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 483

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Yongfei Cai, Jun Zhang, Tianshu Xiao, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 642-648
Open Access | Times Cited: 240

COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 185

Recent advances in regenerative biomaterials
Dinglingge Cao, Jiandong Ding
Regenerative Biomaterials (2022) Vol. 9
Open Access | Times Cited: 146

Lipid nanoparticles in the development of mRNA vaccines for COVID-19
Barnabas Wilson, K. Geetha
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103553-103553
Open Access | Times Cited: 142

Nanoparticle-Based Delivery Systems for Vaccines
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1946-1946
Open Access | Times Cited: 141

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 90

Synthetic Biology: Bottom-Up Assembly of Molecular Systems
Stephan Hirschi, Thomas R. Ward, Wolfgang Meier, et al.
Chemical Reviews (2022) Vol. 122, Iss. 21, pp. 16294-16328
Closed Access | Times Cited: 83

Nanotechnology-based mRNA vaccines
Shuying Chen, Xiangang Huang, Yonger Xue, et al.
Nature Reviews Methods Primers (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 74

The advances of adjuvants in mRNA vaccines
C. Xie, Ruhui Yao, Xiaojun Xia
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44

Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 24

Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
Colin A. Russell, Ron A. M. Fouchier, Parinaz Ghaswalla, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 18

Microfluidics for Nanomedicine Delivery
Kangfu Chen, Hongfen Yang, Ren Cai
ACS Biomaterials Science & Engineering (2025)
Closed Access | Times Cited: 2

Recent advances in the biosynthesis of polysaccharide-based antimicrobial glycoconjugate vaccines
Yuhui Wang, Huan Liu, Baoying Wang, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access | Times Cited: 2

Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 2

DC-Derived Exosomes for Cancer Immunotherapy
Yi Yao, Chunmei Fu, Li Zhou, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3667-3667
Open Access | Times Cited: 78

COVID-19 Vaccines: Adenoviral Vectors
Catherine Jacob-Dolan, Dan H. Barouch
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 41-54
Open Access | Times Cited: 65

COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
Antonella Conforti, Emanuele Marra, Fabio Palombo, et al.
Molecular Therapy (2021) Vol. 30, Iss. 1, pp. 311-326
Open Access | Times Cited: 64

Controversy surrounding the Sputnik V vaccine
Mario Cazzola, Paola Rogliani, Filomena Mazzeo, et al.
Respiratory Medicine (2021) Vol. 187, pp. 106569-106569
Open Access | Times Cited: 60

Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics
Hidefumi Mukai, Koki Ogawa, Naoya Kato, et al.
Drug Metabolism and Pharmacokinetics (2022) Vol. 44, pp. 100450-100450
Open Access | Times Cited: 59

Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 50

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy
Lijuan Duan, Qian Wang, Cuilian Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50

Biomimetic Exosomes: A New Generation of Drug Delivery System
Xudong Wang, Xian Zhao, Youxiu Zhong, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 45

Advances in the polymeric delivery of nucleic acid vaccines
Gang Chen, Bowen Zhao, Elena F. Ruiz, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4081-4109
Open Access | Times Cited: 44

Page 1 - Next Page

Scroll to top